Europe
Consumer healthcare company HRA Pharma will be expanding internationally into the Middle East, with the UAE and Kuwait being the first movers with the iconic footcare care brand Compeed®.
Evonik is committed to offering customers the general-purpose plasticizer DINP on a global basis. The safe and long-lasting use of plasticizers is always Evonik’s top priority..
Major learned societies initiate two-year strategic alliance
Data from more than 1,200 patients of the PROTECT study demonstrate that high levels of the endothelial function biomarker bio-ADM(R) (bioactive Adrenomedullin) indicate residual congestion of heart failure patients.
BioAscent scientists, working in collaboration with teams at the German Cancer Research Center and the Pivot Park Screening Centre as part of the European Lead Factory project, have helped to discover potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.
The companies had to undergo a number of delays as regulatory agencies from across the globe looked closely at the deal to see if there was a potential the combined companies could create a monopoly in the market and stifle competition.
The deal allows Novoheart to merge its MyHeart Platform with Harvard’s tissue-engineered scale model of the heart ventricle and bioreactor technology.
The same shoe size fits everyone with similar feet, but this approach doesn’t work so well for medical treatment.
GlaxoSmithKline announced results from its pivotal DREAMM-2 Phase III trial of belantamab mafodotin in multiple myeloma.
Global specialist in life sciences logistics, Biocair, has been nominated for an environmental sustainability award.
PRESS RELEASES